Canopy Growth Corporation CGC
0.61 USD +0.01 (+2.13%)
At closeNov 11, 2026, 7:31 PM EST
0.61 0.00 +0.33%
After hours · Nov 11, 7:31 PM ET
0.59 Day range 0.62
0.592 52-week range 1.92
- YTD
- -46.93%
- 1 year
- -49.58%
News
fool.com Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors International cannabis net revenue grew 141% year over year to $12.3 million. Cultivation yields have the potential to increase 25% to 30% in the Kincardine facility.
seekingalpha.com Canopy Growth Corporation (WEED:CA) Q2 2027 Earnings Call Transcript Canopy Growth Corporation ( WEED:CA ) Q2 2027 Earnings Call November 6, 2026 10:00 AM EST Company Participants John Vincic Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO…
benzinga.com Why Is Canopy Growth Stock Falling Friday? Canopy Growth stock tumbles 9% after earnings and revenue miss estimates, despite strong cannabis sales and improving EBITDA.
marketbeat.com Canopy Growth Q2 Earnings Call Highlights Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve…
zacks.com Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.01 per share a year ago.
businesswire.com Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives…
benzinga.com Canopy Growth Q2 EPS $(0.07) Misses $(0.03) Estimate, Sales $58.149M Miss $59.120M Estimate Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 600 percent decrease over losses of…
fool.com Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
zacks.com Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
zacks.com Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.
businesswire.com Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives…
marketbeat.com Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board Canopy Growth NASDAQ: CGC shareholders approved all matters presented at the company's reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election…
businesswire.com Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026 SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives…
zacks.com Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors Canopy Growth Corporation (CGC) closed at $0.67 in the latest trading session, marking a -6.67% move from the prior day.
fool.com Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth. Despite last December's Executive Order, efforts to reschedule marijuana remained stymied by bureaucratic gridlock. Canopy Growth shares have tumbled on this regulatory inaction, but that's not the…
fool.com Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its…
zacks.com Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market Canopy Growth Corporation (CGC) closed at $0.71 in the latest trading session, marking a -6.27% move from the prior day.
zacks.com Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
businesswire.com Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives…
fool.com Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA. Tilray Brands has diversified its revenue stream significantly…
247wallst.com Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.
zacks.com Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today Canopy Growth Corporation (CGC) concluded the recent trading session at $0.87, signifying a -1.87% move from its prior day's close.
benzinga.com 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/- benzinga.com Canopy Growth Says Its Kincardine, Ontario Cultivation Facility Receives Renewed EU Good Manufacturing Practice Certification Renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chainCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED)
benzinga.com Canopy Growth Sees Steady Progress on Profitability Measures Canopy Growth beats first-quarter estimates as revenue rises 13%, medical cannabis sales increase, and margins improve on MTL Cannabis integration.
benzinga.com Canopy Growth Q1 EPS $(0.02) Beats $(0.04) Estimate, Sales $58.630M Beat $58.520M Estimate Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 87.5 percent increase over losses of $(0.16)…
benzinga.com Canopy Gwth Reports Q4 2026 Results: Full Earnings Call Transcript 
benzinga.com Earnings Scheduled For June 15, 2026 
benzinga.com Canopy Growth Q4 EPS $(0.29) Misses $(0.06) Estimate, Sales $51.947M Miss $53.260M Estimate Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.06) by 383.33 percent. This is a 71.29 percent increase over losses of…
benzinga.com Trulieve Makes History As First US Cannabis Stock On NYSE https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-the-price-markets-already-are
benzinga.com 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
benzinga.com "Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
benzinga.com Why Akanda Stock Is Surging Wednesday? Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low float dynamics are driving the rally.
benzinga.com Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling strong momentum.
benzinga.com What's Going On With Canopy Growth Stock Thursday? Canopy Growth Corp (NASDAQ:CGC) shares are falling Thursday, pulling back after Wednesday's rally on U.S. cannabis policy shift.- benzinga.com 'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268
benzinga.com Akanda (AKAN) Stock Continues Soaring Overnight Amid Trump Cannabis Reclassification Report: What You Should Know Akanda Corp. shares jump 33.69% after hours following a 214% intraday surge.
benzinga.com Trump's Marijuana Reclassification Plan Sparks Cannabis ETF Rally—Is A Breakout Finally Here? Cannabis ETFs surge as Trump signals Schedule III reclassification, boosting profit outlook and investor interest.
benzinga.com Canopy Growth Stock Surges On Impending Trump Administration Marijuana Reclassification: Report Shares of Canopy Growth (NASDAQ: CGC) are surging Wednesday afternoon following news of a potential major shift in federal cannabis policy.
benzinga.com Trump To Reclassify Marijuana 'As Soon As Wednesday,' But Prediction Markets Are Skeptical Trump is reportedly set to reclassify marijuana this week, but Polymarket traders put the odds at just 32% by June 30. The calendar is the catch.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 'Trump Administration Is Expected To Move To Reclassify Marijuana As Soon As Wednesday' - Axios https://www.axios.com/2026/04/22/trump-marijuana-rule-change
benzinga.com 'White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week'- Marijuana Moment https://www.marijuanamoment.net/white-house-schedules-meeting-on-cannabis-products-enforcement-policy-for-next-week/- benzinga.com 'Marijuana Businesses Could List On US Stock Exchanges Like Nasdaq And NYSE Under New Bipartisan Congressional Bill' - Marijuana Moment https://www.marijuanamoment.net/marijuana-businesses-could-list-on-us-stock-exchanges-like-nasdaq-and-nyse-under-new-bipartisan-congressional-bill/
- benzinga.com 'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_read=1773920530418
benzinga.com Canopy Growth Completes Acquisition Of MTL Cannabis Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) and MTL Cannabis Corp. ("MTL Cannabis" or "MTL") (CSE:MTLC) (OTCQX:MTLNF) today announced the completion of the…- benzinga.com Canopy Growth Secures MTL Cannabis Shareholder Approval For Acquisition Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce that shareholders of MTL Cannabis Corp. ("MTL Cannabis" or "MTL") have voted to approve the…
- benzinga.com 'Federal Agency Finalized Rule For CBD Medicare Coverage Pilot Program Weeks Ago, Key Hemp Stakeholder Says'- Marijuana Moment https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-program-weeks-ago-key-hemp-stakeholder-says/
benzinga.com Is the Market Bullish or Bearish on Canopy Growth Corp? - benzinga.com 'GOP Congressman Isn't Sure Marijuana Rescheduling Is A DOJ 'Priority,' But Remains Optimistic About Progress Under Trump' - Marijuana Moment https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-but-remains-optimistic-about-progress-under-trump/